Dose-ranging Study of PRX-102 in Adult Fabry Disease Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2014 by Protalix
Sponsor:
Information provided by (Responsible Party):
Protalix
ClinicalTrials.gov Identifier:
NCT01678898
First received: August 31, 2012
Last updated: April 4, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)